|
Alan Shaw, Calysta president and CEO, standing in front of the new plant set up in Teesside. (Photo: Stock File)
Calysta sets up aquaculture feed plant in Teesside
(UNITED KINGDOM, 9/20/2016)
US-based Calysta has chosen Teesside as the base for its state-of-the-art facility to manufacture sample quantities of FeedKind® protein, a proprietary, competitively priced new fish and animal feed ingredient targeted at replacing fishmeal.
Leading retailers, producers, investors and government representatives from around the globe have gathered in the north of England to mark the opening of a historic facility that will help meet the protein demands of the world’s growing population.
Sources from the firm explained that produced using the world’s only commercially validated gas fermentation process, FeedKind protein is a natural, traceable and safe non-animal source of protein.
This protein is approved for sale and use in many animal feeds in the EU and has been tested on multiple fish species, including salmon.
The facility will become fully operational in the fourth quarter this year.
Calysta’s representatives recalled that earlier this year the firm partnered with Cargill for production of FeedKind protein in North America and entered into a global joint marketing agreement. A world scale plant is expected to open in the United States by 2018.
In this regard, Alan Shaw, Ph.D, Calysta President and CEO, said: “The opening of this plant represents the end of a decade of development and heralds a new era in the race to sustainably feed the world’s growing population.”
Shaw also pointed out that by 2050 the global population is expected to rise from 7.4 billion today to 9.6 billion and require 70 per cent more protein than is currently available and that Calysta can help meet this need by supplying the aquaculture industry with a naturally produced, sustainable and traceable feed alternative to replace conventional ingredients based on fishmeal and soya.
“Our first focus is the salmon farming industry and we were very pleased to welcome representatives from a number of key producers today. FeedKind protein has been shown to improve growth rates, nitrogen retention and gut health in Atlantic salmon,” Shaw stressed.
The plant is supported by a conditional Exceptional Regional Growth Fund (EGRF) award and represents a total potential investment of GBP 30 million. When completed, the facility is expected to provide employment for 35 to 40 people.
Speaking at the official opening, MP Anna Turley stated: “This facility puts the UK at the forefront of the race to address the world’s growing protein demand with novel technologies. I am really pleased that Calysta have chosen to base their biotech project here and look forward to seeing the facility develop further.”
The official opening at the Wilton Centre was followed by a conference hosted by Calysta to discuss the increasing worldwide demand for fish protein, traceability and sustainability. Representatives from Marine Harvest, Sainsbury’s and Rabobank took part in a panel discussion at the event.
[email protected]
www.seafood.media
Information of the company:
|
Address:
|
1140 O’Brien Drive
|
|
City:
|
Menlo Park
|
|
State/ZIP:
|
California (CA 94025)
|
|
Country:
|
United States
|
|
Phone:
|
+1 (650) 492-6880
|
|
E-Mail:
|
[email protected]
|
More about: 
|
|
|
|
Print
